(CVE) Cenovus Energy - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA15135U1093
Stock: Crude Oil, Bitumen, Diesel, Gasoline, Asphalt
Total Rating 58
Risk 92
Buy Signal 0.60
| Risk 5d forecast | |
|---|---|
| Volatility | 35.9% |
| Relative Tail Risk | -0.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.14 |
| Alpha | 34.46 |
| Character TTM | |
|---|---|
| Beta | 1.154 |
| Beta Downside | 1.768 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.57% |
| CAGR/Max DD | 0.22 |
EPS (Earnings per Share)
Revenue
Description: CVE Cenovus Energy February 11, 2026
Cenovus Energy Inc. (NYSE:CVE) is a Canadian-based integrated oil and gas company that extracts, upgrades, transports, and markets bitumen, heavy oil, natural gas, and refined products across Canada, the United States, and China. Its operations are organized into five segments: Oil Sands (including Foster Creek, Christina Lake, Sunrise, and Lloydminster thermal assets), Conventional, Offshore, Canadian Refining, and U.S. Refining.
Key recent metrics (Q4 2023): production averaged ≈ 593 k boe/d, net earnings were ≈ $2.6 bn, free cash flow reached ≈ $1.1 bn, and total debt stood at ≈ $6.5 bn. The company paid a quarterly dividend of $0.85 per share, reflecting a payout ratio of roughly 45 % of earnings. Core economic drivers include the rebound in WTI crude prices after the OPEC+ supply curtailment cycle, a strengthening Canadian dollar that improves export margins, and ongoing ESG scrutiny that pressures bitumen-heavy portfolios.
For a deeper, data-driven look at Cenovus’s valuation and risk profile, the ValueRay platform provides a concise snapshot worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 3.14b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -4.69 > 1.0 |
| NWC/Revenue: 7.42% < 20% (prev 6.59%; Δ 0.82% < -1%) |
| CFO/TA 0.15 > 3% & CFO 7.85b > Net Income 3.14b |
| Net Debt (8.13b) to EBITDA (9.28b): 0.88 < 3 |
| Current Ratio: 1.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.79b) vs 12m ago -3.79% < -2% |
| Gross Margin: 20.70% > 18% (prev 0.22%; Δ 2048 % > 0.5%) |
| Asset Turnover: 102.6% > 50% (prev 105.2%; Δ -2.62% > 0%) |
| Interest Coverage Ratio: 7.64 > 6 (EBITDA TTM 9.28b / Interest Expense TTM 546.0m) |
Altman Z'' 2.93
| A: 0.08 (Total Current Assets 9.77b - Total Current Liabilities 5.65b) / Total Assets 53.57b |
| B: 0.23 (Retained Earnings 12.23b / Total Assets 53.57b) |
| C: 0.08 (EBIT TTM 4.17b / Avg Total Assets 54.13b) |
| D: 1.11 (Book Value of Equity 28.02b / Total Liabilities 25.18b) |
| Altman-Z'' Score: 2.93 = A |
Beneish M -3.06
| DSRI: 0.90 (Receivables 2.58b/2.98b, Revenue 55.53b/57.54b) |
| GMI: 1.06 (GM 20.70% / 22.03%) |
| AQI: 1.17 (AQ_t 0.10 / AQ_t-1 0.09) |
| SGI: 0.97 (Revenue 55.53b / 57.54b) |
| TATA: -0.09 (NI 3.14b - CFO 7.85b) / TA 53.57b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of CVE shares?
As of February 21, 2026, the stock is trading at USD 22.57 with a total of 10,356,824 shares traded.
Over the past week, the price has changed by +2.78%, over one month by +27.66%, over three months by +25.98% and over the past year by +53.09%.
Over the past week, the price has changed by +2.78%, over one month by +27.66%, over three months by +25.98% and over the past year by +53.09%.
Is CVE a buy, sell or hold?
Cenovus Energy has received a consensus analysts rating of 4.26.
Therefore, it is recommended to buy CVE.
- StrongBuy: 8
- Buy: 9
- Hold: 1
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CVE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.9 | -11.9% |
| Analysts Target Price | 19.9 | -11.9% |
CVE Fundamental Data Overview February 18, 2026
Market Cap CAD = 55.73b (40.71b USD * 1.3691 USD.CAD)
P/E Trailing = 16.9921
P/E Forward = 23.1481
P/S = 0.7885
P/B = 1.9905
P/EG = 0.45
Revenue TTM = 55.53b CAD
EBIT TTM = 4.17b CAD
EBITDA TTM = 9.28b CAD
Long Term Debt = 7.16b CAD (from longTermDebt, last quarter)
Short Term Debt = 342.0m CAD (from shortTermDebt, last quarter)
Debt = 10.03b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.13b CAD (from netDebt column, last quarter)
Enterprise Value = 63.86b CAD (55.73b + Debt 10.03b - CCE 1.90b)
Interest Coverage Ratio = 7.64 (Ebit TTM 4.17b / Interest Expense TTM 546.0m)
EV/FCF = 22.61x (Enterprise Value 63.86b / FCF TTM 2.82b)
FCF Yield = 4.42% (FCF TTM 2.82b / Enterprise Value 63.86b)
FCF Margin = 5.09% (FCF TTM 2.82b / Revenue TTM 55.53b)
Net Margin = 5.66% (Net Income TTM 3.14b / Revenue TTM 55.53b)
Gross Margin = 20.70% ((Revenue TTM 55.53b - Cost of Revenue TTM 44.04b) / Revenue TTM)
Gross Margin QoQ = 23.16% (prev 20.05%)
Tobins Q-Ratio = 1.19 (Enterprise Value 63.86b / Total Assets 53.57b)
Interest Expense / Debt = 0.67% (Interest Expense 67.0m / Debt 10.03b)
Taxrate = 0.85% (11.0m / 1.30b)
NOPAT = 4.14b (EBIT 4.17b * (1 - 0.85%))
Current Ratio = 1.73 (Total Current Assets 9.77b / Total Current Liabilities 5.65b)
Debt / Equity = 0.35 (Debt 10.03b / totalStockholderEquity, last quarter 28.37b)
Debt / EBITDA = 0.88 (Net Debt 8.13b / EBITDA 9.28b)
Debt / FCF = 2.88 (Net Debt 8.13b / FCF TTM 2.82b)
Total Stockholder Equity = 29.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.80% (Net Income 3.14b / Total Assets 53.57b)
RoE = 10.69% (Net Income TTM 3.14b / Total Stockholder Equity 29.39b)
RoCE = 11.42% (EBIT 4.17b / Capital Employed (Equity 29.39b + L.T.Debt 7.16b))
RoIC = 11.26% (NOPAT 4.14b / Invested Capital 36.74b)
WACC = 8.72% (E(55.73b)/V(65.76b) * Re(10.17%) + D(10.03b)/V(65.76b) * Rd(0.67%) * (1-Tc(0.01)))
Discount Rate = 10.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.40%
[DCF Debug] Terminal Value 73.67% ; FCFF base≈3.87b ; Y1≈3.48b ; Y5≈2.97b
Fair Price DCF = 20.58 (EV 46.96b - Net Debt 8.13b = Equity 38.83b / Shares 1.89b; r=8.72% [WACC]; 5y FCF grow -12.58% → 2.90% )
EPS Correlation: -64.42 | EPS CAGR: -55.04% | SUE: -1.73 | # QB: 0
Revenue Correlation: 40.68 | Revenue CAGR: 4.93% | SUE: -0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.20 | Chg30d=-0.038 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=0.89 | Chg30d=-0.109 | Revisions Net=+0 | Growth EPS=-33.6% | Growth Revenue=-23.3%
P/E Trailing = 16.9921
P/E Forward = 23.1481
P/S = 0.7885
P/B = 1.9905
P/EG = 0.45
Revenue TTM = 55.53b CAD
EBIT TTM = 4.17b CAD
EBITDA TTM = 9.28b CAD
Long Term Debt = 7.16b CAD (from longTermDebt, last quarter)
Short Term Debt = 342.0m CAD (from shortTermDebt, last quarter)
Debt = 10.03b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.13b CAD (from netDebt column, last quarter)
Enterprise Value = 63.86b CAD (55.73b + Debt 10.03b - CCE 1.90b)
Interest Coverage Ratio = 7.64 (Ebit TTM 4.17b / Interest Expense TTM 546.0m)
EV/FCF = 22.61x (Enterprise Value 63.86b / FCF TTM 2.82b)
FCF Yield = 4.42% (FCF TTM 2.82b / Enterprise Value 63.86b)
FCF Margin = 5.09% (FCF TTM 2.82b / Revenue TTM 55.53b)
Net Margin = 5.66% (Net Income TTM 3.14b / Revenue TTM 55.53b)
Gross Margin = 20.70% ((Revenue TTM 55.53b - Cost of Revenue TTM 44.04b) / Revenue TTM)
Gross Margin QoQ = 23.16% (prev 20.05%)
Tobins Q-Ratio = 1.19 (Enterprise Value 63.86b / Total Assets 53.57b)
Interest Expense / Debt = 0.67% (Interest Expense 67.0m / Debt 10.03b)
Taxrate = 0.85% (11.0m / 1.30b)
NOPAT = 4.14b (EBIT 4.17b * (1 - 0.85%))
Current Ratio = 1.73 (Total Current Assets 9.77b / Total Current Liabilities 5.65b)
Debt / Equity = 0.35 (Debt 10.03b / totalStockholderEquity, last quarter 28.37b)
Debt / EBITDA = 0.88 (Net Debt 8.13b / EBITDA 9.28b)
Debt / FCF = 2.88 (Net Debt 8.13b / FCF TTM 2.82b)
Total Stockholder Equity = 29.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.80% (Net Income 3.14b / Total Assets 53.57b)
RoE = 10.69% (Net Income TTM 3.14b / Total Stockholder Equity 29.39b)
RoCE = 11.42% (EBIT 4.17b / Capital Employed (Equity 29.39b + L.T.Debt 7.16b))
RoIC = 11.26% (NOPAT 4.14b / Invested Capital 36.74b)
WACC = 8.72% (E(55.73b)/V(65.76b) * Re(10.17%) + D(10.03b)/V(65.76b) * Rd(0.67%) * (1-Tc(0.01)))
Discount Rate = 10.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.40%
[DCF Debug] Terminal Value 73.67% ; FCFF base≈3.87b ; Y1≈3.48b ; Y5≈2.97b
Fair Price DCF = 20.58 (EV 46.96b - Net Debt 8.13b = Equity 38.83b / Shares 1.89b; r=8.72% [WACC]; 5y FCF grow -12.58% → 2.90% )
EPS Correlation: -64.42 | EPS CAGR: -55.04% | SUE: -1.73 | # QB: 0
Revenue Correlation: 40.68 | Revenue CAGR: 4.93% | SUE: -0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.20 | Chg30d=-0.038 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=0.89 | Chg30d=-0.109 | Revisions Net=+0 | Growth EPS=-33.6% | Growth Revenue=-23.3%